halazepam (paxipam) Report issue

Small molecule Approved FDA
ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB

Active Ingredient History

NOW
  • Now
Halazepam is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative and skeletal muscle relaxant properties. Halazepam is used to relieve anxiety, nervousness, and tension associated with anxiety disorders. Halazepam (Paxipam) is no longer commercially available in the United States. Common adverse effects are: hypotension, nausea, xerostomia, confusion, headache. Alcohol should be avoided while taking Paxipam as it causes drowsiness as well. Medications that also cause drowsiness should not be taken along with Paxipam. These include: Antidepressants, Pain relievers, Seizure medications, Muscle relaxants, Antihistamines, Sleeping pills and sedatives.   NCATS

Chemistry

  • SMILES: FC(F)(F)CN1C2=CC=C(Cl)C=C2C(=NCC1=O)C3=CC=CC=C3
  • InChIKey: WYCLKVQLVUQKNZ-UHFFFAOYSA-N
  • Mol. Mass: 352.738
  • ALogP: 4.09
  • ChEMBL Molecule:
    halazepam  
More Chemistry

Pharmacology

Alternative names

7-chloro-1,3-dihydro-5-phenyl-1- (2,2,2-trifluoroethyl)-2h-1,4-benzodiazepin-2-one | halazepam | halazépam | halazepamum | paxipam | sch 12041 | sch-12041

Organizations (2)

Research & Development (0)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Marketing (2)

Organization Org Type FDA approvals Clinical Trials involvement Org ID Force Sort

Indications (2)

Approved Indications (1)


 

Anxiety Disorders (approved 1981)

Experimental Indications - Clinical Trial Phases 1-4 (1)


 

Seizures ()

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue